Ultrasound-Delivered Hydrogen Protects Hearts from Attack Damage
- Authors
- Shu-Hui Wang, Chen-Hui Li, Zi-Jun Wei, Cai-Yun Tang, Yong Wang, Fei Yan, Qian Li
- Journal
- Biomaterials Advances
- Year
- 2026
- DOI
- 10.1016/j.bioadv.2026.214770
- Study Type
- Rat
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Myocardial Infarction
- Body System
- Cardiovascular
TL;DR
Ultrasound-triggered hydrogen microbubbles improved cardiac function and reduced infarct damage after myocardial ischemia/reperfusion by suppressing inflammatory cell death pathways in rats.
Key Finding
Ultrasound-triggered hydrogen-loaded microbubbles significantly improved cardiac function and reduced heart tissue damage in rats with myocardial ischemia/reperfusion injury by suppressing multiple programmed cell death pathways.
Summary
Researchers developed tiny bubbles filled with hydrogen gas that can be injected into the bloodstream and released directly into damaged heart tissue using ultrasound. In rats with heart attack-like injury, this targeted hydrogen delivery improved heart function, reduced the size of damaged areas, and worked by blocking multiple cell death pathways that occur during heart attacks.
Practical Takeaway
This early-stage rat study suggests a novel delivery method for hydrogen gas that could potentially be more effective than drinking hydrogen water, but it is far from human application. The technology requires ultrasound activation and intravenous injection, making it a medical intervention rather than a consumer product. Much more research, including human trials, would be needed before any clinical use.
Abstract
Myocardial ischemia/reperfusion (MIR) injury remains a major clinical challenge with limited therapeutic options. Although molecular hydrogen (H₂) possesses therapeutic potential, its clinical translation is hindered by poor solubility and the lack of targeted delivery and real-time monitoring capabilities. To address this, we developed hydrogen-loaded lipid microbubbles (H₂-MBs) for ultrasound-triggered, spatially controlled H₂ delivery. The fabricated H₂-MBs exhibited uniform spherical morphology (0.92 ± 0.03 μm), high concentration ((1.14 ± 0.07) × 1010 bubbles/mL), and efficient H₂ encapsulation, enabling real-time contrast-enhanced ultrasound imaging. In a rat model of MIR injury, intravenous injection of H₂-MBs followed by ultrasound-targeted microbubble destruction (UTMD) significantly improved cardiac function (ejection fraction and fractional shortening), reduced infarct size, and attenuated tissue damage. Mechanistic studies revealed that ultrasound-targeted H₂ release suppressed H₂O₂-induced PANoptosis-a synergistic cell death pathway-by concurrently downregulating key mediators of pyroptosis (cleaved caspase-1, GSDMD), apoptosis (cleaved caspase-3/8, Bax/Bcl-2 ratio), and necroptosis (p-RIPK1, p-RIPK3, p-MLKL). Our work presents a robust theranostic microsystem for image-guided, spatiotemporally controlled gas delivery, offering a promising strategy to combat MIR injury through coordinated modulation of inflammatory programmed cell death.